Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chromosome Region Associated with Increased Risk for Melanoma

By Labmedica staff writers
Posted on 27 May 2008
Scientists have identified a region on chromosome 20 (20q11.22) that influences a person's risk of developing melanoma.

Prolonged exposure to the suns harmful ultraviolet (UV) rays can lead to melanoma, the deadliest form of skin cancer. More...
An unanswered question, however, is why some people are more prone to develop melanoma than others are.

A team of investigators from the Translational Genomic Research Institute (TGen; Phoenix, AZ, USA) and the Queensland Institute of Medical Research (QIMR; Queensland, Australia) is close to discovering a new gene that could help explain variation in melanoma risk. The scientists narrowed the gene location through a genome-wide association study--a first in melanoma research. The study--whose data collection began 20 years ago--involved more than 4,000 Australian samples (2,019 cases and 2,105 controls) and was a joint project between Australian, American, and European research groups.

A genome-wide association study involves scanning the DNA from two sets of individuals: those with a particular disease (cases) and those of similar individuals without the disease (controls). The DNA of each sample is then examined for strategically selected markers of genetic variation, called single nucleotide polymorphisms (SNPs). If certain genetic variations are found to be significantly more frequent in people with the disease compared to people without disease, those variations are said to be "associated” with the disease. The associated genetic variations can serve as roadmaps to the region of the human genome where the disease-causing gene resides.

Dr. Kevin Brown, TGen investigator commented, "We're closing in on genetic variants which cause 16% of the population to be at nearly double the increased risk of developing the disease. In public health terms, this finding is highly significant.”


Related Links:
The Translational Genomic Research Institute
Queensland Institute of Medical Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.